Literature DB >> 6988524

Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.

D C Anderson, M S Edwards, C J Baker.   

Abstract

A luminol-enhanced chemiluminescence (CL) assay was developed to evaluate type III group B streptococcal opsonins. Sera from 11 adults that contained high (greater than 25 microgram/ml), intermediate (3-24 microgram/ml), or low (less than 2 microgram/ml) antibody concentrations were assessed by CL, indirect immunofluorescence (IF), and bactericidal assays. Total CL activity correlated with antibody concentration (P less than 0.005), IgG- and C3-IF values, and phagocytic and bactericidal indices. Heat-stable CL activity correlated with antibody concentration (P less than 0.0001) and was related to IgG-IF values and phagocytic indices. Significant bactericidal activity was demonstrated in all sera containing greater than 2 microgram of antibody/ml, but no bactericidal activity was observed in heat-inactivated sera. Adsorption of heated sera with type III group B Streptococcus abolished CL activity, whereas CL values of MgEGTA-chelated sera were approximately 80% of untreated sera. Thus, type-specific antibody in addition to heat-labile serum factors, including those of the alternative complement pathway, contribute to opsonization of type III group B Streptococcus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988524     DOI: 10.1093/infdis/141.3.370

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.

Authors:  S Takahashi; Y Nagano; N Nagano; O Hayashi; F Taguchi; Y Okuwaki
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  Haemophilus influenzae type b opsonins of intravenous immunoglobulins.

Authors:  S Bender; S Hetherington
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

3.  Opsonization of various capsular (K) E. coli by the alternative complement pathway.

Authors:  P Stevens; L S Young; S Adamu
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

4.  Chemiluminescence assay for detection of anti-platelet antibodies.

Authors:  J E Menitove; M E Frenzke; S W Braem; R H Aster
Journal:  Klin Wochenschr       Date:  1982-06-01

5.  Variations in the opsonic requirements of group B streptococcus type III.

Authors:  M J Hastings; C S Easmon
Journal:  Br J Exp Pathol       Date:  1981-10

6.  Interaction of soluble fibronectin with group B streptococci.

Authors:  K M Butler; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Authors:  S L Kaplan; C L Umstead; E O Mason; D C Anderson; J C Parke; R D Feigin
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

8.  Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci.

Authors:  F J Noya; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Generation of chemotactic activity in serum by Haemophilus influenzae type b.

Authors:  M F Tosi; S L Kaplan; E O Mason; G J Buffone; D C Anderson
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.

Authors:  D C Anderson; B J Hughes; C W Smith
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.